echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Sexually active young women have the highest rates of HPV infection, and experts are calling for girls aged 9-14 to be vaccinated

    Sexually active young women have the highest rates of HPV infection, and experts are calling for girls aged 9-14 to be vaccinated

    • Last Update: 2021-02-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    "It's already a leaching cancer, and the chances of surgery are slim!" Only 16-year-old Deng Li (alias) uneasy came to Beijing University Shenzhen Hospital obstetrics and gynecology, the whole person appears extremely thin, pale, eyes like just cried red and swollen up, the doctor asked her about the situation, her tone covered up, half a day later whispered and the doctor said that he was because of vaginal secretion increased, irregular bleeding before coming to the hospital.
    to Deng Li's description, the hand seemed to touch the bag, the doctor's mind flashed a bad idea - "cervical cancer."
    , through a biopsy, Deng Li was diagnosed with cervical cancer and developed into a stage of leaching cancer.
    decades ago cervical cancer was still a tumor in middle-aged and older women, but now young women are getting more and more common.
    Ruifang, director of the Obstetrics and Gynaecology Center at Peking University's Shenzhen Hospital, said that after questioning, it was found that early sexuality and multiple sexual partners were important reasons for Deng Li's cervical cancer.
    One woman dies of cervical cancer every 10 minutes in China, and the proportion of young women aged ≤35 with cervical cancer has risen over the past 30 years, wu said, noting that the data show that the trend in younger people is mainly related to the lifestyle of young people, with the highest rate of HPV infection among young sexually active women.
    " has received a woman in her 30s, after a successful career before being pregnant, in the pre-pregnancy examination found that is already terminal cervical cancer, after a series of preoperative chemotherapy, the full uterus plus double-sided attachment excision, but always lost fertility, " and such a tragedy, in fact, women can completely avoid happening! High-risk HPV persistent infection is the root cause of cervical cancer of all the world's malignant tumors, only cervical cancer by medical researchers to find the real cause, simply put, high-risk HPV persistent infection.
    Wu Ruifang, a professor at the University of Hong Kong, said hpV infection rates among young people are not low because the virus is mainly sexually transmitted.
    According to foreign research statistics, a woman's lifetime cumulative infection rate can reach more than 90%, but that is not to say that as long as the HPV virus will eventually lead to the occurrence of cervical cancer, only high-risk HPV persistent infection can cause cervical cancer, currently recognized with cervical cancer-related subtypes have 14 species.
    " Even if infected with high-risk HPV, many people are also a sexual infection, in the young, immune group of 90% of people infected after the natural detox, only less than 10% of the cause of persistent infection, usually from HPV infection to the occurrence of cervical cancer at least 6-8 years, and even 10-20 years to cervical cancer.
    " Professor Wu Ruifang said that in the clinical HPV infection to the occurrence of cervical cancer there is also a stage of precancerog cancer lesions, precancerog cancer because HPV is more specific to infect the cervical squamous column junction cells, and cause Scaly endoblastoma changes, squamous endothelioma becomes CIN, it is divided into CIN1, CIN2, CIN3, CIN2 and CIN3 are considered to occur in pre-cancer lesions, CIN1 most can be naturally reversed.
    " can be found early before CIN3, women can kill cervical cancer in the cradle.
    " by symptoms found that most of the cervical cancer has been in the middle and late stages of many women want to be able to detect cancer early through clinical symptoms, but unfortunately, cervical cancer in the early stages of almost no clinical symptoms, even to the hospital, the naked eye is difficult to distinguish the early symptoms.
    Wu pointed out that the clinical manifestations of cervical cancer will have an increase in secretions, irregular bleeding, late stage there are lumps, when such symptoms do not appear when none is early.
    early detection of cervical cancer must be detected through screening, including cytology and HPV testing.
    " cytological test is to find abnormal cells that may develop into cancer in the future, and when you see such abnormal cells, further diagnose them to see if there are early lesions or early cancers.
    " Wu Ruifang introduced.
    hpV detection, is the use of cervical cancer shedding cells to detect the virus inside it, there are viruses, positive patients, there is the cause of cervical cancer, there may be cervical cancer in the future.
    negative prediction for HPV testing can reach more than 99%, that is, HPV detection negative people have less than 1% chance of developing the disease.
    , for patients who are screened positive, further biopsies under the vaginal mirror are required to see if they have precancer lesions or cancer.
    9-14 years of age on the HPV vaccine early screening is already a secondary prevention, hpV vaccination for women is a first-level prevention, the combination of the two, can achieve the best prevention results.
    Wu Ruifang said it is best to get a cervical cancer vaccine before the first sex without exposure to the HPV virus, women after the age of 9 can be vaccinated.
    because natural infection also produces antibodies, but natural infections produce antibodies that do not protect, and vaccine immunogenicity is stronger than natural HPV virus, so there is better immunogenicity.
    in addition to the vaccine it also has advents, advents and antigens made together to inject, the advent has played a role in strengthening the immune response, with better immunogenicity, that is, people can produce stronger resistance to such a role.
    " has always stressed the need for early screening, so many years ago, found that cervical cancer screening coverage in the country less than 30%, far from enough, then early cervical cancer vaccination is a good remedy.
    " Professor Wu Ruifang cautions that in addition to the lack of awareness of vaccination among women in remote and poor areas, many urban white-collar workers are often found to have neglected vaccination or cervical cancer screening.
    39 Health Network Source: 39 Health Network Copyright Notice: All text, images and audio and video materials on this website that indicate "Source: Mets Medicine" or "Source: MedSci Original" are owned by Mets Medical, are not authorized, may not be reproduced by any media, website or individual, and shall be reproduced with the words "Source: Mets Medicine".
    all reprinted articles on this website are for the purpose of transmitting more information and clearly indicate the source and author, and media or individuals who do not wish to be reproduced may contact us and we will delete them immediately.
    at the same time reproduced content does not represent the position of this site.
    leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.